Atossa Genetics (ATOS) IPO Trades Lower
Tweet Send to a Friend
Up)
The IPO for Atossa Genetics (NASDAQ: ATOS) is trading at $4.70 per share after pricing 800,000 shares at $5.
Dawson James Securities, Inc. is the sole book-running manager for this offering.
Atossa Genetics, Inc., The Breast Health Company, is based in Seattle, Washington, and is focused on the prevention of breast cancer through the commercialization of diagnostic medical devices and tests that can detect precursors to breast cancer, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Dawson James Securities, Inc. is the sole book-running manager for this offering.
Atossa Genetics, Inc., The Breast Health Company, is based in Seattle, Washington, and is focused on the prevention of breast cancer through the commercialization of diagnostic medical devices and tests that can detect precursors to breast cancer, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Atossa Genetics (ATOS) Enters Agreement for ForeCYTE Test with HealthSmart
- CDW Corp (CDW) Commences IPO; Will Sell 27.9M Common Shares
- Russia's Lenta Said to Select Bankers for Massive IPO - Reuters
Create E-mail Alert Related Categories
IPOs
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
